Rhythm Pharmaceuticals, Inc. — Revenue by Fiscal Year
10 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/8e0464bd-62b6-4a08-8899-a057def7baff/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2025 | $189.8M | 2025-01-01 – 2025-12-31 | evidence 0001628280-26-012399 |
| FY 2024 | $130.1M | 2024-01-01 – 2024-12-31 | evidence 0001558370-25-001889 |
| FY 2023 | $77.4M | 2023-01-01 – 2023-12-31 | evidence 0001558370-24-002181 |
| FY 2022 | $23.6M | 2022-01-01 – 2022-12-31 | evidence 0001558370-24-002181 |
| FY 2021 | $3.2M | 2021-01-01 – 2021-12-31 | evidence 0001558370-24-002181 |
| FY 2020 | $0 | 2020-01-01 – 2020-12-31 | evidence 0001558370-21-002121 |
| FY 2019 | $0 | 2019-01-01 – 2019-12-31 | evidence 0001558370-20-001896 |
| FY 2018 | $0 | 2018-01-01 – 2018-12-31 | evidence 0001558370-20-001896 |
| FY 2017 | $0 | 2017-01-01 – 2017-12-31 | evidence 0001558370-20-001896 |
| FY 2016 | $0 | 2016-01-01 – 2016-12-31 | evidence 0001558370-18-001923 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
Rhythm Pharmaceuticals, Inc. — all facts · Net Income · Operating Income